The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Summary
Progress in the field of insomnia since 2017 necessitated this update of the European Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its comorbidities are: clinical interview (encompassing sleep and medical history); the use of sleep questionnaires and diaries (and physical examination and additional measures where indicated) (A). Actigraphy is not recommended for the routine evaluation of insomnia (C), but may be useful for differential‐diagnostic purposes (A). Polysomnography should be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep‐related breathing disorders, etc.), treatment‐resistant insomnia (A) and for other indications (B). Cognitive‐behavioural therapy for insomnia is recommended as the first‐line treatment for chronic insomnia in adults of any age (including patients with comorbidities), either applied in‐person or digitally (A). When cognitive‐behavioural therapy for insomnia is not sufficiently effective, a pharmacological intervention can be offered (A). Benzodiazepines (A), benzodiazepine receptor agonists (A), daridorexant (A) and low‐dose sedating antidepressants (B) can be used for the short‐term treatment of insomnia (≤ 4 weeks). Longer‐term treatment with these substances may be initiated in some cases, considering advantages and disadvantages (B). Orexin receptor antagonists can be used for periods of up to 3 months or longer in some cases (A). Prolonged‐release melatonin can be used for up to 3 months in patients ≥ 55 years (B). Antihistaminergic drugs, antipsychotics, fast‐release melatonin, ramelteon and phytotherapeutics are not recommended for insomnia treatment (A). Light therapy and exercise interventions may be useful as adjunct therapies to cognitive‐behavioural therapy for insomnia (B).
Top-30
Journals
|
10
20
30
40
50
60
|
|
|
Journal of Sleep Research
54 publications, 12.22%
|
|
|
Sleep Medicine
28 publications, 6.33%
|
|
|
Sleep Medicine Reviews
12 publications, 2.71%
|
|
|
Sleep
11 publications, 2.49%
|
|
|
Scientific Reports
9 publications, 2.04%
|
|
|
Frontiers in Psychiatry
8 publications, 1.81%
|
|
|
Nature and Science of Sleep
7 publications, 1.58%
|
|
|
Journal of Clinical Medicine
6 publications, 1.36%
|
|
|
BMJ Open
6 publications, 1.36%
|
|
|
International Journal of Clinical and Health Psychology
6 publications, 1.36%
|
|
|
BMC Psychiatry
6 publications, 1.36%
|
|
|
Somnologie
5 publications, 1.13%
|
|
|
Frontiers in Pharmacology
5 publications, 1.13%
|
|
|
Frontiers in Neurology
5 publications, 1.13%
|
|
|
Journal of Clinical Sleep Medicine
4 publications, 0.9%
|
|
|
Journal of Behavioral and Cognitive Therapy
4 publications, 0.9%
|
|
|
Cureus
4 publications, 0.9%
|
|
|
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
4 publications, 0.9%
|
|
|
Brain Sciences
3 publications, 0.68%
|
|
|
Psychotherapy and Psychosomatics
3 publications, 0.68%
|
|
|
Expert Opinion on Drug Safety
3 publications, 0.68%
|
|
|
Der Nervenarzt
3 publications, 0.68%
|
|
|
Clocks & Sleep
3 publications, 0.68%
|
|
|
Cochrane Database of Systematic Reviews
3 publications, 0.68%
|
|
|
Sleep Medicine: X
3 publications, 0.68%
|
|
|
Clinical and Translational Neuroscience
2 publications, 0.45%
|
|
|
Brazilian Journal of Physical Therapy
2 publications, 0.45%
|
|
|
Pharmaceuticals
2 publications, 0.45%
|
|
|
Journal of Psychiatric Research
2 publications, 0.45%
|
|
|
10
20
30
40
50
60
|
Publishers
|
20
40
60
80
100
120
|
|
|
Elsevier
113 publications, 25.57%
|
|
|
Springer Nature
81 publications, 18.33%
|
|
|
Wiley
76 publications, 17.19%
|
|
|
Taylor & Francis
31 publications, 7.01%
|
|
|
MDPI
26 publications, 5.88%
|
|
|
Frontiers Media S.A.
25 publications, 5.66%
|
|
|
Oxford University Press
15 publications, 3.39%
|
|
|
BMJ
10 publications, 2.26%
|
|
|
SAGE
10 publications, 2.26%
|
|
|
JMIR Publications
8 publications, 1.81%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 1.36%
|
|
|
Georg Thieme Verlag KG
5 publications, 1.13%
|
|
|
Media Sphere Publishing House
5 publications, 1.13%
|
|
|
The American Academy of Sleep Medicine
4 publications, 0.9%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
4 publications, 0.9%
|
|
|
S. Karger AG
3 publications, 0.68%
|
|
|
Baishideng Publishing Group
3 publications, 0.68%
|
|
|
Remedium, Ltd.
2 publications, 0.45%
|
|
|
Cambridge University Press
2 publications, 0.45%
|
|
|
American Physiological Society
1 publication, 0.23%
|
|
|
Research Square Platform LLC
1 publication, 0.23%
|
|
|
Mary Ann Liebert
1 publication, 0.23%
|
|
|
Massachusetts Medical Society
1 publication, 0.23%
|
|
|
Mark Allen Group
1 publication, 0.23%
|
|
|
American Medical Association (AMA)
1 publication, 0.23%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.23%
|
|
|
F1000 Research
1 publication, 0.23%
|
|
|
Ediciones Universidad de Salamanca
1 publication, 0.23%
|
|
|
IMR Press
1 publication, 0.23%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.23%
|
|
|
20
40
60
80
100
120
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.